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ABSTRACT 
Purpose 
Abnormal proliferation of adventitial vasa vasorum (vv) occurs early at sites of 
atherosclerosis and is thought to be an early biomarker of vascular damage.  Contrast-
enhanced ultrasound (CEUS) can detect this process. Its usefulness in irradiated arteries as 
a measure of accelerated atherosclerosis is unknown.  This study investigates contrast 
intensity in carotid adventitia as an early marker of radiation-induced damage in head and 
neck cancer (HNC) patients. 
 
Materials/Methods 
Patients with HNC treated with a wedged-pair and matched neck technique or hemi-neck 
radiotherapy (RT) (unirradiated side as control) at least 2 years previously were included.  
Patients had been prescribed a dose of at least 50 Gy to the neck.  CEUS was performed on 
both carotid arteries and a region of interest was selected in the adventitia of the far wall of 
both left and right distal common carotid arteries. Novel quantification software was used to 
compare the average intensity per pixel between irradiated and unirradiated arteries.  
 
Results 
48 patients (34 males) with median age of 59.2 yrs (interquartile range (IQR) 49.2 – 64.2) 
were included.  The mean maximum point dose to the irradiated artery was 61.2 Gy (IQR 
52.6 – 61.8) and 1.1 Gy (IQR 1.0 – 1.8 Gy) to the unirradiated side.  The median interval 
from RT was 59.4 months (IQR 41 – 88.7).   There was a significant difference in the mean 
(SD) contrast intensity per pixel on the irradiated side (1.1 (0.4)) versus 0.96 (0.34) on the 
unirradiated side (p=0.01).  After attenuation correction, the difference in mean contrast 
intensity per pixel was still significant (1.4 (0.58) versus 1.2 (0.47) (p=0.02).  Previous 
surgery or chemotherapy had no effect on the difference in contrast intensity between the 2 
sides of the neck.  Mean intensity per pixel did not correlate to traditional risk prediction 
models (carotid intima-medial thickness, QSTROKE score). 
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Conclusions 
Proliferation of vv is demonstrated by increased contrast intensity in irradiated carotid 
arteries. This may be a useful, independent biomarker of radiation-induced carotid 
atherosclerosis when used as a tool to quantify neovascularisation.   
 
Keywords: biomarker, carotid, radiotherapy, atherosclerosis, neovascularisation, contrast-
enhanced ultrasound 
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INTRODUCTION 
 
Vasa vasorum (vv) are a plexus of microvessels located in the adventitia of most medium 
and large arteries (including the aorta, coronary, femoral and carotid arteries).  Their function 
is primarily related to the nutritional needs of veins and arteries.  Researchers have 
demonstrated an increase in the density of adventitial vv before the development of 
atherosclerotic lesions in porcine coronary arteries (1).  Herrmann et al (2) further reported 
that increase in the density of adventitial vv occurs before the onset of endothelial 
dysfunction (one of the first functional alterations in atherosclerosis).  Studies in humans 
have identified plaque neovascularization as a key feature of vulnerable plaques, i.e. those 
plaques at risk of rupture (3, 4).  Furthermore, abnormal proliferation of human adventitial vv 
occurs early at sites of atherosclerosis and is thought to be a precursor to atherosclerosis 
and an early biomarker of vascular damage (4, 5).   
 
Contrast-enhanced ultrasound (CEUS) imaging of the carotid arteries enables the 
acquisition of real-time carotid images with enhancement of the arterial lumen and plaque 
morphology, improved resolution of CIMT, and, importantly, direct visualization of the 
adventitial vv and plaque neovascularization (6-8).  This is an attractive diagnostic tool due 
to its non-ionizing nature and real-time imaging with good spatial resolution, relatively low 
cost and high accessibility.  Contrast agents used in CEUS are microbubbles.  These are 
small (2 to 8 μm) acoustically-active particles composed of a gaseous core of 
perfluorocarbons surrounded by a biocompatible shell composed of a combination of lipids, 
albumin, or polymers (6).  When exposed to an ultrasound beam, these particles expand 
and contract, creating backscatter and, consequently, enabling them to act as echo 
enhancers.  Techniques with multi-pulse sequence transmission and signal processing have 
been widely used to improve the imaging specificity of microbubbles and have made it 
possible to image and quantify neovascularization in plaques and in adventitial vv (4, 9-13).  
However, current quantification of contrast enhancement is limited by spatially 
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heterogeneous and patient-specific attenuation (14, 15).  Accounting for these variables will 
allow for improved quantification of signal intensity from CEUS as a measure of adventitial 
neovascularization.  Some studies have already attempted to correct for attenuation (14, 16, 
17).   
 
The aim of this study was to examine the contrast intensity in the adventitial vv of irradiated 
arteries and compare this to unirradiated arteries.  We hypothesized that radiation-induced 
injury results in an inflammatory response in the endothelium and consequent proliferation of 
adventitial vv, which may be measured quantitatively using CEUS.  The effect of surgery, as 
well as RT, to the neck was also studied and the difference in contrast intensity between 
irradiated and unirradiated carotid arteries was correlated to the interval from RT to see if 
contrast intensity increases early after RT.  In addition, this study aimed to see if there is any 
correlation between contrast intensity and validated markers for risk prediction (carotid 
intima-medial thickness (CIMT) and QSTROKE score).   
MATERIALS AND METHODS 
 
Head and neck cancer patients treated with RT (minimum dose of 50 Gy) to one side of the 
neck prior to December 2009 were included in the study.  Risk factor determination was 
performed as follows – medical history, blood pressure, body mass index, blood glucose, 
and lipid profile.  Ethical approval was obtained from a regional Research Ethics Committee 
and the protocol for the study was reviewed by the Royal Marsden Committee for Clinical 
Research and registered on clinicaltrials.gov (NCT02060643). 
 
Study assessments 
 
Head and neck cancer patients treated prior to December 2009 were prospectively identified 
via the Royal Marsden Hospital head and neck RT database.  Written informed consent was 
obtained from each participant and medication history and co-morbidities were recorded.  
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Blood pressure, height and weight (to determine body mass index) were measured and 
electrocardiogram (ECG) was performed.  Blood samples were taken for haemoglobin, 
plasma glucose, lipid profile, renal and liver profile.  
 
Definitions 
The following definitions were used in this study: 
 Hypertension – systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure 
(DBP) ≥ 90 mmHg 
 Diabetic – random serum glucose ≥ 11.1 mmol/L, a glycosylated haemoglobin A1c 
(HbA1c) ≥5.8%  or current use of glucose-lowering agents or insulin 
 Hyperlipidaemia – fasting serum low density lipoprotein (LDL) ≥ 2.6mmol/L, high density 
lipoprotein (HDL) < 2.3 mmol/L or triglycerides (TG) ≥ 2.3 mmol/L, or current use of 
cholesterol-lowering agents.  Normal ranges: HDL cholesterol -1.0 – 2.3 mmol/L; LDL 
cholesterol - <2.6 mmol/L; TG (fasting) - <2.3 mmol/L (ideal = <1.5 mmol/L); Total 
cholesterol – 3.6 - 8.0 mmol/L (non-fasting) (ideal = <5.0 mmol/L (fasting)), Total 
cholesterol/HDL ratio <5    
 Smoking history – smoker (pack years) or non-smoker/ex-smoker > 10 years 
 Normal BMI – 18.5 – 24.9 kg/m2 
 Overweight –  25.0 – 29.9 kg/m2 
 Obese – ≥30 kg/m2 
 Atrial fibrillation – standard ECG changes 
 Stroke – sudden onset of a neurological deficit persisting for ≥ 24 hours 
 Transient ischaemic attack (TIA) – focal neurological symptoms lasting < 24 hours 
 
Ultrasound studies 
 
CEUS image sequences were acquired on both sides of the neck with a clinical scanner (GE 
Vivid7 with a 9 MHz broadband linear array transducer) using a contrast-specific imaging 
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pre-set. Contrast-enhanced ultrasound video loops were taken using a commercially 
available ultrasound contrast agent, SonoVueTM (Bracco, Milan) given as an intravenous 
infusion via a peripheral vein at a rate of 1.2 mL/min.  The infusion was delivered over a total 
of 5-7 minutes.  Imaging was performed in real-time prior to the arrival of and following the 
saturation of the carotid artery with SonoVue. 
 
CEUS quantification 
 
An attenuation correction and image normalization algorithm for CEUS carotid artery images 
was utilized and has been previously described (18) in order to reduce the effects of any 
non-uniform transducer-skin contact and heterogeneity in tissue attenuation on 
quantification. Analysis of CEUS video sequences was performed offline using software 
developed using Matlab (The Mathworks Inc., Natick, MA, USA). Regions of interest (ROIs) 
were selected manually, one to segment the lumen and the others to include regions in 
adventitia where quantification was required (18). The motion of the lumen and adventitial 
ROIs in the video sequence was tracked and corrected by employing a piece-wise block 
matching algorithm (19). As a result of motion correction, all images in the sequence were 
aligned to the first image.  As the size of the ROIs differed for each video sequence, the 
average intensity per pixel was calculated by dividing the total intensity for the ROI by the 
ROI size (which was calculated in pixels).  This was undertaken for video sequences 
obtained before (subtraction) and after contrast infusion. 
 
CIMT 
B-mode imaging using a 9 MHz linear array transducer prior to infusion of contrast agent 
was utilized to visualize the CIMT.  The common carotid (CCA) and the proximal portion of 
the internal carotid (ICA) and external carotid arteries (ECA) on both sides of the neck were 
examined with the patient supine on an examination couch.  Four-beat video loops (long-
axis and short-axis) were stored for offline analysis.  
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CIMT was determined offline using semi-automated edge-detection software.  
Measurements were blinded as clinical details were not available at the time of analysis.  
Magnified still images were used for analysis and measurements were taken from the far 
wall of the CCA away from any atherosclerotic plaque, 1 cm proximal to the bulb.  Mean 
CIMT was recorded and the average of 3 readings was taken for each measurement.   
 
QSTROKE score 
The QSTROKE score was specifically designed to aid general practitioners in predicting a 
patient’s risk of developing a stroke and is based on the presence of atherosclerotic risk 
factors.  A 10-year risk of cardiovascular disease of 20% or greater is considered high risk, 
and <10% is considered low risk (20).  The Q-STROKE (2014) score was calculated for 
each patient using an online calculator (www.qstroke.org).  Details of each patient’s age, 
sex, race, co-morbidities, medication, systolic blood pressure, body mass index and 
cholesterol to high-density lipoprotein (HDL) ratio were inputted into the calculator to 
determine a percentage 10-year risk. 
 
Statistical analysis 
 
Patient characteristics were summarised using descriptive statistics.  Quantitative variables 
were expressed as means (+/- standard deviations) and medians (including ranges).  
Qualitative variables were expressed as frequencies and percentages.   
 
The mean contrast intensity (before and after attenuation correction) in the irradiated 
adventitia versus the mean contrast intensity in the unirradiated adventitia was compared 
using a paired t-test.  The effect of interval from RT, chemotherapy and surgery on contrast 
intensity was investigated using multiple linear regression.  Correlation of contrast intensity 
to CIMT, QSTROKE and serum biomarkers was undertaken using Spearman’s rank 
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correlation.  Contrast intensity in irradiated and unirradiated arteries before contrast infusion 
was compared using a paired t-test.  
 
All statistical tests were considered two-tailed with significant difference at the p<0.05 level 
for statistical tests performed to test a single hypothesis.  The Bonferroni correction was 
applied for the effect of surgery and chemotherapy on contrast intensity and the α was set at 
0.025.  When the contrast intensity was correlated to the time from RT and CIMT, the 
Bonferroni correction was applied and the α was set at 0.005. This was done as a number of 
tests were run to test a single hypothesis.  Statistical analyses were carried out using Stats 
Direct Medical Statistics and Graphpad Prism 6 statistical packages.   
RESULTS 
 
CEUS images for 48 patients were available for analysis.  One patient declined intravenous 
contrast due to poor venous access and one patient had significant motion during the study 
due to coughing and, therefore, the algorithm was unable to track the vessel adequately.  
Patient characteristics are presented in Table 1.  The mean maximum dose to the irradiated 
artery was 61.2 Gy (IQR 52.6 – 61.8) and 1.1 Gy (IQR 1.0 – 1.8 Gy) to the unirradiated 
carotid artery.  The median interval from RT was 59.4 months (IQR 41 – 88.7). 
 
Contrast intensity  
 
There was a significant difference in the mean (SD) contrast intensity per pixel on the 
irradiated side (1.1 (0.4)) compared to 0.96 (0.34) on the unirradiated side (p=0.01).  After 
attenuation correction, the difference in mean contrast intensity per pixel was still significant 
(1.4 (0.58) versus 1.2 (0.47) (p=0.02)) (Figure 1a+b). 
 
We compared the contrast intensity before contrast (subtraction images) between the 
irradiated and unirradiated side.  There was no difference between the signal intensity 
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before contrast infusion in irradiated (mean 0.55 (SD = 0.18)) versus unirradiated (mean 
0.51 (SD = 0.18) (p = 0.12) arteries, suggesting that there was no significant difference in 
tissue homogeneity between irradiated and unirradiated arteries before contrast infusion. 
 
Effect of surgery and chemotherapy 
 
There was no difference in contrast intensity in patients who had a neck dissection 
compared to those who had not.  The same was true for patients who had received 
chemotherapy or not, suggesting that the difference seen between the irradiated and 
unirradiated side was predominantly due to RT.  These results are shown in table 2. 
 
Correlation to validated markers for stroke risk 
 
CIMT 
 
As ROIs were selected on the far wall of the distal CCA, we compared the difference in 
mean distal CCA CIMT between irradiated – unirradiated arteries to the difference in 
contrast intensity between irradiated – unirradiated arteries (Figure 2).  There was no 
significant correlation between CIMT and contrast intensity either before or after attenuation 
correction. 
 
QSTROKE score 
 
There was no correlation between contrast intensity and QSTROKE score for both the 
irradiated and unirradiated side of the neck.  The correlation coefficient (r) of uncorrected 
contrast intensity to QSTROKE for the irradiated neck was -0.06 (p=0.68); corrected contrast 
intensity, r = 0.07 (p=0.64). For the unirradiated neck, the correlation coefficient of 
uncorrected contrast intensity to QSTROKE was -0.15 (p=0.31); for corrected contrast 
intensity, r = 0.002 (p=0.99). 
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Interval from RT 
 
The correlation of adventitial contrast intensity difference (irradiated – unirradiated) to 
interval from RT is shown in figure 3 (attenuation-corrected images).  This shows no 
correlation between the interval from RT and the difference in contrast intensity between the 
two sides of the neck.  This suggests that contrast intensity does not increase steadily over 
time.  Rather, it is more likely that this increase following RT occurs at a certain time point 
and then remains stable over time.  As all patients had been treated at least 2 years 
previously, it is probable that this process occurs prior to 2 years following RT. 
DISCUSSION 
 
This study has demonstrated a significant difference in contrast intensity between irradiated 
and unirradiated carotid arteries with novel software that utilizes an attenuation correction 
and image normalization method.   This is strengthened by the fact that no significant 
difference was seen between the two sides of the neck on subtraction images (i.e. before 
the infusion of contrast).  Attenuation artefacts in CEUS images, together with other factors, 
can make reliable quantification difficult and lead to diagnostic uncertainty. This is the first 
study, as far as we are aware, to utilize attenuation and normalisation techniques for CEUS 
quantification in irradiated carotid arteries.  In addition, the use of internal controls within the 
same patient makes this an attractive model for investigating increased contrast intensity 
following RT.    
 
The intensity per pixel parameter derived in this study has not been utilized before and 
requires validation in a longitudinal study and correlation to histological samples.   We 
believe, however, that the average intensity per pixel will be more representative of changes 
occurring in the adventitia and less likely to over- or underestimate contrast intensity in the 
adventitia.    
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There have been studies investigating adventitial vv proliferation in other settings.  Sampson 
et al (21) investigated carotid vv ratio (semi-automated software was used to derive the 
video intensity in the adventitia over the video intensity in the lumen) in diabetic and non-
diabetic patients.  They demonstrated that vv ratio was unrelated to CIMT, but both 
parameters were independently associated with diabetes.  This is in keeping with the 
findings from our study, which showed no correlation between contrast intensity difference 
between the two sides of the neck and CIMT.  It is therefore possible that vv proliferation 
may be an independent risk factor for atherosclerosis but this would require further 
investigation in longitudinal studies.   
 
It is important to note, however, that there are considerable methodological differences in 
that our study considered the intensity per pixel rather than a 2 mm area of adventitia.  Both 
studies considered 2-dimensional views of the arterial vessel with selection of a small region 
of interest.  Therefore, measurements obtained may not be representative of the entire 
vessel.  What is clear, however, is that both studies demonstrate increased contrast uptake 
in high-risk groups and our study has the advantage of using matched internal controls.  In 
addition, we have corrected for attenuation artefacts with our quantification software, which 
were not accounted for in the other study.  In CEUS, pseudo-enhancement artefact 
originating from tissues could be present due to ultrasound non-linear propagation (22, 23). 
To rule out the possibility that different tissue echogenicity caused the difference in CEUS 
signals in our study, non-contrast video loops of arteries on both sides of the neck were 
obtained prior to contrast infusion.  There was no significant difference in adventitial intensity 
between the two sides of the neck prior to contrast and, therefore, we are confident that 
differences in intensity between the two sides following contrast infusion were likely to have 
been due to the contrast uptake in the adventitial vv. 
 
Schinkel et al (24) used CEUS to assess carotid wall vascularization in a cohort of patients 
with large vessel vasculitis (Takayasu or giant cell arteritis) using a previously published 
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qualitative grading method (25).  They reported carotid wall vascularization in 64% of carotid 
arteries (29% of which were graded as severe wall vascularization).  The authors did note 
that previously reported pseudo-enhancement artefact (26, 27) may over-estimate contrast 
activity in the far wall.  The study did demonstrate, however, increased contrast intensity in a 
vasculitic process, supporting the premise that adventitial vv proliferation is part of an 
inflammatory process that may be detected by CEUS.  
 
What is still uncertain is whether the increased contrast intensity is due to proliferation of vv 
or some other process related to RT-induced damage e.g. perivascular and/or intravascular 
fibrosis.  Correlation of CEUS features with histological features would provide further 
clarification. The contrast intensity difference does not increase with interval from RT and 
this suggests that, once the intensity increases due to whatever process is occurring, it 
remains relatively stable over time.  
 
There was no correlation between the contrast intensity difference and the difference in the 
distal CCA CIMT or the QSTROKE score.  Therefore, further prospective work is required to 
determine if this imaging biomarker is truly an early marker of radiation-induced 
atherosclerosis.  Prospective data using this model of matched internal controls would 
provide useful information about the timing of adventitial vv proliferation after RT and its 
correlation to CIMT at different time points.  It is also possible that this marker is an 
independent biomarker and may correlate to the final end-point of stroke or TIA but long-
term data are required to clarify this.  An early imaging biomarker of radiation-induced 
atherosclerosis would allow for detection of preclinical changes in the carotid artery and risk 
stratification of patients for monitoring and risk reduction therapies, as well as the 
assessment of response to antiatherosclerotic therapies.  This technique may also be useful 
to assess the success of carotid-sparing RT techniques. 
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Ultimately, longitudinal data are required to determine if CEUS may be useful as an imaging 
biomarker for radiation-induced damage.  The use of targeted microbubbles to activated 
leukocytes (28) may be more useful in identifying changes in both plaques and the adventitia 
after RT.  In addition, the use of 3-D ultrasound techniques may provide a more 
representative picture of the processes occurring in the arterial wall and plaques.  
CONCLUSION 
 
We have demonstrated that contrast intensity is significantly increased in irradiated carotid 
arteries and may be a useful imaging biomarker for radiation-induced atherosclerosis.  Our 
study supports previous data that this biomarker may be independently associated with 
vascular damage and is not associated to CIMT.   Studies in other high-risk groups have 
shown increased contrast uptake in keeping with an inflammatory process.  Refinement of 
CEUS techniques to account for attenuation artifact and pseudoenhancement in the far wall 
of the carotid artery is still required but we have gone some way in addressing these issues. 
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Figures and Tables 
 
Figure 1.  Contrast adventitial intensity in irradiated (red) versus unirradiated (green) 
arteries a) before attenuation correction and b) after attenuation correction (p significant if 
<0.05).  The horizontal black lines represent the mean and SD. 
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Figure 2.  Correlation of distal CCA CIMT difference (irradiated – unirradiated) and contrast 
intensity difference (irradiated – unirradiated) a) before and b) after attenuation correction (p 
significant if <0.005) 
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Figure 3.  Correlation of contrast intensity difference (irradiated – unirradiated) and interval 
from RT (p significant if <0.005) 
 
 22 
Table 1. Patient demographics 
 
Demographic characteristics/risk factors Number (%) (N=48) 
Female 15 (31%) 
Age in years, median (interquartile range) 59.2 (49.2 – 64.2) 
Histology Squamous 38 (79%) 
Non-squamous 10 (21%) 
Tumour Grade Well Differentiated 2 (4%) 
Moderate Differentiated 8 (17%) 
Poorly Differentiated 25 (52%) 
Unknown 13 (27%) 
Tumour Stage  0 7 (15%) 
1 20 (42%) 
2 17 (35%) 
3 1 (2%) 
4 3 (6%) 
Nodal Status 0 11 (23%) 
1 10 (21%) 
2 27 (56%) 
Neck Dissection 31 (65%) 
Induction Chemotherapy 7 (15%) 
Concomitant Chemotherapy 22 (46%) 
RT dose to neck 
(Gy) 
50 Gray 19 (40%) 
60 Gray 28 (58%) 
 63 Gray 1 (2%) 
Interval since radiotherapy (months) 59.4 (41- 88.7) 
Risk Factors Diabetes 4 (8%) 
Hypertension 12 (28%) 
Dyslipidaemia 11 (23%) 
Smoker 25 (52%) 
Body Mass Index (kg/m2) (median (IQR)) 26.5 (23.2 – 28.4) 
Medication Aspirin 12 (28%) 
ACE Inhibitors 4 (8%) 
5-HMG Co-reductase 
Inhibitor 
13 (27%) 
Total Cholesterol (mmol/L) 5.1 (4.6 - 5.8) 
Low Density Lipoproteins (mmol/L) 3.3 (2.6 - 3.7) 
High Density Lipoproteins (mmol/L) 1.4 (1.2 – 1.7) 
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Table 2.  Effect of surgery and chemotherapy on adventitial contrast intensity before 
attenuation correction (uncorr) and after correction (corr) (p is significant if <0.025) 
 
Contrast intensity per pixel 
  Irradiated 
Median (IQR) 
P value Unirradiated 
Median (IQR) 
P value 
UNCORR Neck dissection 1.1 (0.83 – 1.4) 0.80 1.1 (0.61 – 1.6) 0.70 
No neck dissection 1.1 (0.95 – 1.3) 0.86 (0.71 – 1.1) 
CORR Neck dissection 1.4 (0.85 – 1.8) 0.94 1.3 (0.81 – 1.5) 0.14 
No neck dissection 1.3 (1.1 – 1.6) 0.97 (0.85 – 1.2) 
UNCORR Chemotherapy 1.1 (0.92 – 1.3) 0.75 0.81 (0.63 – 1.2) 0.17 
No chemotherapy 1.1 (0.68 - .3) 1.1 (0.77 – 1.3) 
CORR Chemotherapy 1.5 (1.1 – 1.7) 0.42 0.91 (0.79 – 1.5) 0.16 
No chemotherapy 1.2 (0.95 – 1.7) 1.3 (0.96 – 1.5) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
